Projected Income Statement: Albemarle Corporation

Forecast Balance Sheet: Albemarle Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 1,955 1,718 3,277 2,324 1,576 1,123 -179 -829
Change - -12.12% 90.75% -29.08% -32.19% -28.72% -115.94% -363.13%
Announcement Date 16/02/22 15/02/23 14/02/24 12/02/25 11/02/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Albemarle Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 953.7 1,262 2,149 1,686 589.8 566.5 662.6 726.7
Change - 32.29% 70.36% -21.56% -65.01% -3.95% 16.97% 9.67%
Free Cash Flow (FCF) 1 -609.4 646.2 -824 -983.7 692.5 1,179 1,404 1,286
Change - 206.04% -227.51% -19.39% 170.39% 70.25% 19.11% -8.4%
Announcement Date 16/02/22 15/02/23 14/02/24 12/02/25 11/02/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Albemarle Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 26.17% 47.48% 35.05% 21.2% 21.35% 46.27% 47.36% 44.5%
EBIT Margin (%) 18.54% 43.37% 30.57% 10.25% 8.54% 28.97% 27.99% 29.14%
EBT Margin (%) 4.02% 33.24% 2.57% -32.8% -10.74% 19.38% 21.34% 24.27%
Net margin (%) 3.72% 36.75% 16.36% -24.47% -13.17% 19.44% 29.31% 33.02%
FCF margin (%) -18.31% 8.83% -8.57% -18.29% 13.46% 18.39% 21.42% 18.87%
FCF / Net Income (%) -492.76% 24.02% -52.37% 74.75% -102.23% 94.62% 73.07% 57.13%

Profitability

        
ROA 4.39% 19.57% 15.54% -1.58% -0.56% 9.66% 11.31% 12.52%
ROE 8.31% 19.01% 30.12% -2.84% -0.95% 17.1% 15.93% 13.48%

Financial Health

        
Leverage (Debt/EBITDA) 2.24x 0.49x 0.97x 2.04x 1.43x 0.38x - -
Debt / Free cash flow -3.21x 2.66x -3.98x -2.36x 2.28x 0.95x - -

Capital Intensity

        
CAPEX / Current Assets (%) 28.66% 17.24% 22.35% 31.35% 11.47% 8.84% 10.11% 10.66%
CAPEX / EBITDA (%) 109.49% 36.3% 63.77% 147.91% 53.72% 19.1% 21.34% 23.95%
CAPEX / FCF (%) -156.49% 195.24% -260.85% -171.37% 85.17% 48.05% 47.19% 56.5%

Items per share

        
Cash flow per share 1 2.972 16.2 11.25 5.974 10.9 11.33 12.77 13.69
Change - 445.01% -30.52% -46.91% 82.41% 3.97% 12.73% 7.16%
Dividend per Share 1 1.56 1.58 1.6 1.61 1.62 1.623 1.651 1.667
Change - 1.28% 1.27% 0.63% 0.62% 0.22% 1.68% 0.95%
Book Value Per Share 1 48.07 67.77 80.17 84.74 80.99 86.77 93.9 106.1
Change - 40.97% 18.3% 5.69% -4.43% 7.14% 8.21% 13.03%
EPS 1 1.06 22.84 13.36 -11.2 -5.76 10.69 11.73 14.34
Change - 2,054.72% -41.51% -183.83% 48.57% 285.5% 9.75% 22.29%
Nbr of stocks (in thousands) 1,16,976 1,17,153 1,17,353 1,17,540 1,17,698 1,17,935 1,17,935 1,17,935
Announcement Date 16/02/22 15/02/23 14/02/24 12/02/25 11/02/26 - - -
1USD
Estimates
2026 *2027 *
P/E 11.1x 10.1x
PBR 1.37x 1.26x
EV / Sales 2.36x 2.11x
Yield 1.37% 1.39%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
118.71USD
Average target price
187.16USD
Spread / Average Target
+57.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALB Stock
  4. Financials Albemarle Corporation